Background/Objectives: Capsaicin is the principal pungent compound in chili peppers and is increasingly recognized as a multifunctional phytochemical with systemic effects beyond its sensory properties. It has been linked to metabolic regulation, neuroprotection, inflammation control, and cancer modulation. This review aims to provide an integrative synthesis of capsaicin’s metabolism, its interaction with the gut microbiome, and its physiological implications across organ systems. Methods: We conducted a critical literature review of recent in vivo and in vitro studies exploring capsaicin’s metabolic fate, biotransformation by host enzymes and gut microbes, tissue distribution, and molecular pathways. The literature was analyzed thematically to cover gastrointestinal absorption, hepatic metabolism, microbiota interactions, and systemic cellular responses. Results: Capsaicin undergoes extensive hepatic metabolism, producing hydroxylated and dehydrogenated metabolites that differ in transient receptor potential vanilloid type 1 (TRPV1) receptor affinity and tissue-specific bioactivity. It crosses the blood–brain barrier, alters neurotransmitter levels, and accumulates in brain regions involved in cognition. In addition to its systemic effects, capsaicin appears to undergo microbial transformation and influences gut microbial composition, favoring short-chain fatty acid producers and suppressing pro-inflammatory taxa. These changes contribute to anti-obesity, anti-inflammatory, and potentially anticancer effects. Dose-dependent adverse outcomes, such as epithelial damage or tumor promotion, have also been observed. Conclusions: Capsaicin represents a diet-derived bioactive molecule whose systemic impact is shaped by dynamic interactions between host metabolism and the gut microbiota. Clarifying its biotransformation pathways and context-specific effects is essential for its safe and effective use in metabolic and neurological health strategies.

The global production of biomethane is rapidly emerging as a sustainable alternative to fossil fuels for energy generation. Biogas, where methane (CH4) is usually one of the main components, is generated through the anaerobic digestion (AD) of various organic substrates, including animal manure, organic wastes, and wastewater. The efficiency of the AD process depends on key operational parameters and reactor designs that optimize microbial activity and gas yield. However, inhibitory compounds such as heavy metals, ammonia, and volatile fatty acids (VFAs) can significantly impact microbial metabolism and biogas production. To enhance substrate availability for microbial degradation, different pretreatment methods are often employed, as well as current advances in the AD focused on DIET enhancement and co-digestion technologies. This chapter provides a comprehensive overview of common substrates for AD, the impact of operational parameters, and strategies to mitigate the effects of inhibitory compounds. It also examines the latest advancements in reactor designs for effective monitoring and control of the digestion process. Additionally, the chapter explores biogas production for electrical energy generation, along with the purification technologies required to upgrade biogas to biomethane. Finally, it discusses the applications and value-added products derived from biomethane and its integration into circular economy frameworks. It involves the advantages and gaps hindering the full implementation of AD-derived energy worldwide.